We Can Medicines Statistics

Total Valuation

TPEX:6929 has a market cap or net worth of TWD 1.55 billion. The enterprise value is 2.57 billion.

Market Cap	1.55B
Enterprise Value	2.57B

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6929 has 44.97 million shares outstanding. The number of shares has increased by 5.11% in one year.

Current Share Class	44.97M
Shares Outstanding	44.97M
Shares Change (YoY)	+5.11%
Shares Change (QoQ)	-1.12%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	1.17%
Float	5.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.48
PB Ratio	1.40
P/TBV Ratio	1.41
P/FCF Ratio	7.82
P/OCF Ratio	6.28
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.00, with an EV/FCF ratio of 12.97.

EV / Earnings	-36.44
EV / Sales	0.79
EV / EBITDA	14.00
EV / EBIT	n/a
EV / FCF	12.97

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 1.16.

Current Ratio	1.61
Quick Ratio	0.58
Debt / Equity	1.16
Debt / EBITDA	7.00
Debt / FCF	6.49
Interest Coverage	-2.79

Financial Efficiency

Return on equity (ROE) is -6.19% and return on invested capital (ROIC) is -1.83%.

Return on Equity (ROE)	-6.19%
Return on Assets (ROA)	-1.44%
Return on Invested Capital (ROIC)	-1.83%
Return on Capital Employed (ROCE)	-3.34%
Revenue Per Employee	3.23M
Profits Per Employee	-70,058
Employee Count	1,005
Asset Turnover	1.02
Inventory Turnover	2.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.96% in the last 52 weeks. The beta is -0.48, so TPEX:6929's price volatility has been lower than the market average.

Beta (5Y)	-0.48
52-Week Price Change	-51.96%
50-Day Moving Average	36.89
200-Day Moving Average	44.49
Relative Strength Index (RSI)	48.96
Average Volume (20 Days)	7,793

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6929 had revenue of TWD 3.25 billion and -70.41 million in losses. Loss per share was -1.58.

Revenue	3.25B
Gross Profit	1.07B
Operating Income	-73.09M
Pretax Income	-74.70M
Net Income	-70.41M
EBITDA	2.02M
EBIT	-73.09M
Loss Per Share	-1.58

Full Income Statement

Balance Sheet

The company has 264.13 million in cash and 1.28 billion in debt, giving a net cash position of -1.02 billion or -22.66 per share.

Cash & Cash Equivalents	264.13M
Total Debt	1.28B
Net Cash	-1.02B
Net Cash Per Share	-22.66
Equity (Book Value)	1.11B
Book Value Per Share	24.93
Working Capital	530.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 246.16 million and capital expenditures -48.34 million, giving a free cash flow of 197.82 million.

Operating Cash Flow	246.16M
Capital Expenditures	-48.34M
Free Cash Flow	197.82M
FCF Per Share	4.40

Full Cash Flow Statement

Margins

Gross margin is 32.95%, with operating and profit margins of -2.25% and -2.17%.

Gross Margin	32.95%
Operating Margin	-2.25%
Pretax Margin	-2.30%
Profit Margin	-2.17%
EBITDA Margin	0.06%
EBIT Margin	-2.25%
FCF Margin	6.09%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 0.79%.

Dividend Per Share	0.27
Dividend Yield	0.79%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-5.11%
Shareholder Yield	-4.32%
Earnings Yield	-4.55%
FCF Yield	12.79%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a